{
    "clinical_study": {
        "@rank": "35278", 
        "arm_group": {
            "arm_group_label": "aneurysmal subarachnoid hemorrhage", 
            "description": "observational, no intervention"
        }, 
        "brief_summary": {
            "textblock": "In patients suffering from aneurysmal subarachnoid hemorrhage (aSAH), hyperglycemia is\n      considered an adverse prognostic factor. Glycated hemoglobin (or HbA1c) can be measured to\n      estimate the average plasma glucose concentration over prolonged periods of time, thus\n      determination of glycated hemoglobin at admission after aSAH serves as an approximation of\n      blood glucose levels in the weeks preceding aneurysm rupture. In this patient registry\n      admission HbA1c, clinical course and neurological outcome after 6 month are recorded, to\n      determine whether elevated blood glucose levels prior to aneurysm rupture influence the\n      clinical course and patient outcome after aSAH."
        }, 
        "brief_title": "Admission HbA1C in Aneurysmal Subarachnoid Hemorrhage", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hyperglycemia", 
            "Aneurysmal Subarachnoid Hemorrhage"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Hyperglycemia", 
                "Subarachnoid Hemorrhage"
            ]
        }, 
        "detailed_description": {
            "textblock": "In patients suffering from aneurysmal subarachnoid hemorrhage (aSAH), hyperglycemia is\n      considered an adverse prognostic factor. Glycated hemoglobin (or HbA1c) can be measured to\n      estimate the average plasma glucose concentration over prolonged periods of time, thus\n      determination of glycated hemoglobin at admission after aSAH serves as an approximation of\n      blood glucose levels in the weeks preceding aneurysm rupture.\n\n      In this patient registry admission HbA1c within 72 hours after confirmed aneurysmal\n      subarachnoid hemorrhage in patients aged over 18 years is determined and correlated with\n      clinical course and neurological outcome after 6 month as determined by modified Rankin\n      score. Additionally, patients are monitored for incidence of delayed cerebral ischemia (DCI)\n      and the incidence of new infarction on the discharge ct scan attributable to DCI. General\n      treatment of cerebral aneurysm and subarachnoid hemorrhage in all patients follows\n      international guidelines."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  confirmed aneurysmal subarachnoid hemorrhage\n\n          -  admission within 72hours after hemorrhage\n\n          -  Age >18 years\n\n        Exclusion Criteria:\n\n          -  non-aneurysmal SAH\n\n          -  admission >72hours after hemorrhage\n\n          -  Age <18 years"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients with confirmed aneurysmal subarachnoid hemorrhage admitted within 72 hours to\n        our department aged over 18 years."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 28, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02081820", 
            "org_study_id": "UKD-NCH-2014-001"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "hyperglycemia", 
            "aneurysmal subarachnoid hemorrhage", 
            "glycated hemoglobin", 
            "outcome", 
            "DCI"
        ], 
        "lastchanged_date": "March 5, 2014", 
        "link": {
            "description": "Homepage of the Department of Neurosurgery, Heinrich-Heine-University D\u00fcsseldorf", 
            "url": "http://www.neurochirurgie.uni-duesseldorf.de/"
        }, 
        "location": {
            "contact": {
                "email": "beseoglu@med.uni-duesseldorf.de", 
                "last_name": "Kerim Beseoglu, M.D.", 
                "phone": "0049-211-81", 
                "phone_ext": "19727"
            }, 
            "facility": {
                "address": {
                    "city": "D\u00fcsseldorf", 
                    "country": "Germany", 
                    "state": "NRW", 
                    "zip": "40225"
                }, 
                "name": "Department of Neurosurgery, Heinrich-Heine-University D\u00fcsseldorf"
            }, 
            "investigator": {
                "last_name": "Kerim Beseoglu, M.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_groups": "1", 
        "official_title": "Observational Study on the Prognostic Relevance of Admission Glycated Hemoglobin (HbA1C) in Patients With Aneurysmal Subarachnoid Hemorrhage", 
        "overall_contact": {
            "email": "beseoglu@med.uni-duesseldorf.de", 
            "last_name": "Kerim Beseoglu, M.D.", 
            "phone": "0049-211-81-", 
            "phone_ext": "19727"
        }, 
        "overall_official": {
            "affiliation": "Department of Neurosurgery, Heinrich-Heine-University, D\u00fcsseldorf", 
            "last_name": "Kerim Beseoglu, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Institute for Drugs and Medical Devices", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "modified Rankin score", 
            "safety_issue": "No", 
            "time_frame": "6 month after discharge"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02081820"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Heinrich-Heine University, Duesseldorf", 
            "investigator_full_name": "Neurochirurgische Klinik, Universit\u00e4tsklinikum D\u00fcsseldorf", 
            "investigator_title": "Neurochirurgische Klinik, Universit\u00e4tsklinikum D\u00fcsseldorf", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Incidence of new infarction on discharge ct scan not attributable to causes other then DCI.", 
            "measure": "Incidence of DCI related new infarction on discharge ct scan", 
            "safety_issue": "No", 
            "time_frame": "at discharge, approx. 14-21days after admission"
        }, 
        "source": "Heinrich-Heine University, Duesseldorf", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Heinrich-Heine University, Duesseldorf", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "6 Months", 
        "verification_date": "March 2014"
    }
}